HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials (2013)
- Authors:
- Autor USP: MANO, MAX SENNA - FM
- Unidade: FM
- DOI: 10.1016/j.ctrv.2013.01.002
- Subjects: NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA); REAÇÃO EM CADEIA POR POLIMERASE; MARCADOR MOLECULAR; QUIMIOTERAPIA ADJUVANTE; ESTUDOS PROSPECTIVOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Cancer Treatment Reviews
- ISSN: 0305-7372
- Volume/Número/Paginação/Ano: v. 39, n. 6, p. 622-631, 2013
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DENT, Susan et al. HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials. Cancer Treatment Reviews, v. 39, n. 6, p. 622-631, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ctrv.2013.01.002. Acesso em: 03 jan. 2026. -
APA
Dent, S., Oyan, B., Honig, A., Mano, M., & Howell, S. (2013). HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials. Cancer Treatment Reviews, 39( 6), 622-631. doi:10.1016/j.ctrv.2013.01.002 -
NLM
Dent S, Oyan B, Honig A, Mano M, Howell S. HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials [Internet]. Cancer Treatment Reviews. 2013 ; 39( 6): 622-631.[citado 2026 jan. 03 ] Available from: https://doi.org/10.1016/j.ctrv.2013.01.002 -
Vancouver
Dent S, Oyan B, Honig A, Mano M, Howell S. HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials [Internet]. Cancer Treatment Reviews. 2013 ; 39( 6): 622-631.[citado 2026 jan. 03 ] Available from: https://doi.org/10.1016/j.ctrv.2013.01.002 - Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial
- Value of systemic staging in asymptomatic early breast cancer
- Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1
- Reply to [Carta]: mastectomy skin flap thickness
- O uso do Oncotype DX® na indicação de quimioterapia adjuvante - experiência do Hospital Sírio-Libanês
- Pneumonite não-infecciosa em paciente com tumor neuroendócrino tratado com everolimus (EVR)
- Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy
- A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)
- Return to work after breast cancer diagnosis: An observational prospective study of 125 patients in South America
- Malignancy-related hypercalcemia in the bishosphonate era
Informações sobre o DOI: 10.1016/j.ctrv.2013.01.002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
